Scientists reprogram patient’s cells to reverse Type 1 diabetes

Researchers in China have achieved a significant medical advancement by reprogramming a female patient's stem cells to reverse Type 1 diabetes. The 25-year-old woman, who had been diagnosed with the condition, has maintained insulin independence for over a year following the treatment. This innovative approach has enabled her body to resume natural insulin production, thereby eliminating the necessity for daily insulin injections. This case marks a notable milestone in the pursuit of effective treatments for Type 1 diabetes.

Read More